Aug 30, 2023
Steve Kent is Chief Product Officer at Know Labs, which has developed a new sensor that uses noninvasive radiofrequency spectroscopy to measure molecules in the body. Their first target is to non-invasively measure glucose to help those with diabetes manage their conditions more effectively. As a sensor and diagnostics company, Know Labs is working to understand how its sensor and technology can be integrated with best-in-class insulin delivery systems to provide a portable, reliable, and affordable solution for a growing global audience.
Steve explains, "It's a big breakthrough as far as what you're able to measure by being able to penetrate deeper into the human body. Also, we can send up to 400,000 different frequencies through one sensor, whereas, with LEDs, as the example I gave earlier, you can only send something like three to five per LED. Then, you have to physically change out the entire sensor. With ours, that programmatic control allows us an unprecedented amount of new data through the sensor field."
"The sensor has a very sophisticated control unit in it. It's programmable. Today, we can connect it to laptops. It can be connected through a cable. It can be connected through WiFi or Bluetooth to any other companion device. Right now, it's very powerful in that we can have full programmable control over how the device works in the world and understand the scenarios that allow it to perform the best. The short answer is yes, it can connect to an iPhone or an Android, and then I think there are still questions we're looking to solve on the best possible patient experience. I could envision the data being shown on your phone. The device itself may also be able to provide you with a reading directly. There are still some questions to answer there as far as what is the best experience for our future customers."
@TheKnowLabs #KnowLabs #Diabetes #GlucoseMonitoring #MedicalDevices #DiabetesManagement #NoninvasiveGlucoseMonitoring
